Opioid Rehab Near You: MAT, Detox & Recovery Programs
Browse SAMHSA-listed opioid rehab programs across all 50 states — filter by MAT type (buprenorphine, methadone, naltrexone), level of care (OTP, OBOT, residential, IOP, telehealth), and insurance acceptance. MAT reduces opioid overdose deaths by more than 50% (NIDA), yet fewer than 20% of people with OUD receive it. Synthetic opioids (primarily fentanyl) drive ~75% of US opioid overdose deaths — CDC reports over 80,000 annually. After the 2023 MAT Act, any licensed prescriber can offer buprenorphine in office-based or telehealth settings.
Found 9,319 rehab centers specializing in opioid addiction across the United States.
Need Help Finding the Right Treatment Center?
Speak with a compassionate specialist now - 100% free & confidential
Find Opioid Treatment Centers Near You
Browse opioid treatment centers below. Filter by MAT availability, state, insurance, and level of care to find the right program for your recovery needs.
Showing 20 of 9319 results
Situated in Dorchester, MA, the Gavin Foundation provides extensive long-term residential and round-the-clock treatment for adult males facing substance use challenges. This center emphasizes 12-step facilitation, anger management strategies, and brief intervention methods. It also features specialized programs aimed at seniors or older individuals, offering personalized support for this age group. Concentrating on the needs of adult men, including seniors and young adults, the center guarantees high-quality care specifically designed for its male clientele. The Gavin Foundation is distinguished by its all-encompassing services and customized treatment plans, making it a premier option for those in search of effective and specialized support for addiction recovery.
Situated in Boston, MA, the Gavin Foundation specializes in long-term and around-the-clock residential treatment programs designed for adult men and older individuals. This center offers focused support for seniors and those facing addiction in their young adulthood. Emphasizing 12-step methodologies, anger management techniques, and brief intervention strategies, the facility provides thorough assistance for those aiming to overcome substance use issues. The Gavin Foundation's male-oriented program highlights individualized care and a nurturing atmosphere that promotes sustained recovery. With a strong dedication to exceptional treatment, this center serves as a vital support system for people on their recovery journeys.
At Gaudenzia Inc in Erie, PA, we are dedicated to providing effective, research-backed therapeutic interventions for individuals struggling with substance use disorders and concurrent serious mental health challenges, as well as emotional difficulties in youth. Our offerings include intensive, regular, and standard outpatient care, drawing upon proven methods such as cognitive behavioral therapy, contingency management, and the Matrix Model. Gaudenzia Inc emphasizes personalized treatment plans for adults and young people of any gender, ensuring that each person receives high-quality, gender-affirming care specifically designed for their individual recovery path.
Situated in Erie, PA, Gaudenzia Inc provides exceptional rehabilitation services tailored for women and older adults. With an emphasis on treating substance abuse and co-occurring mental health issues, the facility offers extended residential programs that incorporate 12-step methodologies, brief interventions, and cognitive behavioral approaches. This center is distinguished by its targeted initiatives for adult women, those who have faced sexual trauma or abuse, and young adults dealing with significant emotional difficulties. Gaudenzia Inc fosters a nurturing and secure atmosphere for those in need of thorough and individualized support to tackle addiction and mental health obstacles.
Gaudenzia Inc in Bristol, PA, serves those in need of extensive addiction recovery solutions through a variety of targeted services. The center features residential detox services alongside multiple residential treatment options designed for adults and young adults dealing with substance use issues and concurrent mental health conditions. Utilizing approaches such as 12-step programs, brief interventions, and cognitive behavioral therapy, the facility delivers research-backed treatment. Special programs are available for adult men and women, as well as for individuals who have suffered from intimate partner or domestic violence. Gaudenzia Inc in Bristol prioritizes high-quality care for all clients, fostering a nurturing atmosphere conducive to healing.
The Gavin Foundation, situated in Boston, MA, specializes in a wide array of treatment services for substance use disorders, serving both adults and youth. This facility offers various levels of care, including intensive and standard outpatient programs, as well as medication-assisted treatment with methadone, buprenorphine, or naltrexone. Emphasizing 12-step support, anger management, and short intervention techniques, the center addresses the needs of those facing both addiction and significant mental health challenges. There are dedicated services for both men and women to provide customized support for each group. The Gavin Foundation is committed to delivering effective, gender-responsive treatment to aid individuals in their recovery journey.
Situated in Middleburg, PA, Gaudenzia Inc provides extensive services for substance use recovery through its intensive outpatient, outpatient, and outpatient programs featuring methadone, buprenorphine, or naltrexone. The center employs evidence-based methods such as cognitive behavioral therapy, the Matrix Model, and motivational interviewing to address the needs of adults, adolescents, men, and women. Gaudenzia Inc offers specialized programs designed for different age groups and genders, ensuring individualized treatment for each patient. With a strong focus on high-quality care and a variety of treatment options, Gaudenzia Inc serves as an essential resource for individuals pursuing effective addiction recovery in the Middleburg community.
Situated in Philadelphia, PA, Gaudenzia Inc specializes in extended residential care and transitional living arrangements for women facing challenges related to substance use disorders. This center features tailored programs for those who have undergone experiences of intimate partner violence, domestic violence, or sexual assault. Emphasizing a 12-step methodology along with anger management and short intervention strategies, Gaudenzia Inc is committed to providing personalized support for adult and senior women on their path to recovery within a nurturing setting. For anyone seeking effective addiction recovery solutions with a focus on women's needs, this center is devoted to guiding women towards sustained sobriety and holistic health.
Gaudenzia Inc, situated in Erie, Pennsylvania, delivers extensive treatment options for adult men battling substance use issues within a nurturing and organized setting. The center offers various services, including long-term residential care, transitional housing, and halfway housing. Emphasizing methods such as 12-step programs, anger management, and brief intervention techniques, Gaudenzia Inc is dedicated to aiding individuals in their recovery path. Tailored specifically for adult males, this establishment serves adults, seniors, and young adults alike. With continuous support and an all-male environment, Gaudenzia Inc guarantees a secure and effective rehabilitation experience for those in need of assistance with addiction.
Situated in West Chester, PA, Gaudenzia Inc provides an extensive array of substance abuse treatment options for both adults and young adults facing dual diagnosis issues. This center offers various programs, including long-term, short-term, and around-the-clock residential care, designed to meet individual requirements. Gaudenzia Inc features specialized tracks for adult men, adult women, and individuals impacted by intimate partner violence, ensuring each client receives tailored support. Their treatment methodologies incorporate evidence-based practices such as 12-step facilitation, anger management strategies, and brief intervention methods. Dedicated to delivering high-quality care, this facility accommodates both male and female participants in pursuit of successful recovery solutions.
Situated in McConnellsburg, PA, Gaudenzia Inc specializes in a wide range of treatment options for adults and seniors dealing with substance use issues. The center offers various levels of care, including intensive outpatient services, outpatient treatment, and standard outpatient programs. Utilizing proven methods such as 12-step facilitation, cognitive behavioral therapy, and the Matrix Model, Gaudenzia Inc is committed to providing effective support. A distinguishing feature of this center is its personalized treatment approach, allowing for tailored care that addresses the specific needs of each individual. With dedicated programs available for both men and women, Gaudenzia Inc fosters a welcoming and supportive community. Count on Gaudenzia Inc for exceptional, customized addiction treatment solutions.
Situated in Mechanicsburg, PA, Gaudenzia Inc offers a variety of treatment options for adults and seniors dealing with substance use issues. The center features intensive outpatient, outpatient, and standard outpatient programs, delivering customized care through proven methods such as 12-step facilitation, cognitive behavioral therapy, and the Matrix Model. Gaudenzia Inc is distinguished by its specialized programs designed for both male and female clients. Their commitment to personalized treatment plans ensures each individual receives focused support throughout their recovery process. For those seeking thorough addiction treatment in a nurturing atmosphere, Gaudenzia Inc may be an excellent option.
Situated in Sunbury, PA, Gaudenzia Inc delivers exceptional care for substance use disorders with diverse methodologies such as cognitive behavioral therapy, the Matrix Model, and motivational interviewing. The center features intensive outpatient care, standard outpatient services, as well as outpatient treatments utilizing methadone, buprenorphine, or naltrexone. Gaudenzia Inc also offers specialized programs designed for adolescents, adult men, and adult women, catering to various age brackets and gender identities, including children and teens. This facility is recognized for its all-encompassing and individualized approach to addiction recovery, making it an excellent choice for those seeking help for themselves or loved ones.
Gaudenzia Inc, situated in Pottsville, PA, delivers extensive treatment options for substance use disorders. The center features intensive outpatient programs, outpatient services, and treatments utilizing methadone/buprenorphine or naltrexone. It focuses on methods such as cognitive behavioral therapy, the Matrix Model, and motivational interviewing. Gaudenzia Inc offers specialized programs designed for adolescents, men, and women, catering to adults as well as children and teens of any gender. Patients can anticipate receiving high-quality care and assistance from a committed group of professionals, making this center a great option for those needing tailored and effective addiction recovery services.
Gaudenzia Inc, situated in Lewisburg, PA, delivers thorough substance use rehabilitation for adult men and women. This center features intensive outpatient care, standard outpatient services, and medication-assisted treatment options including methadone, buprenorphine, or naltrexone. Employing proven therapeutic methods like cognitive behavioral therapy, the Matrix Model, and motivational interviewing, the facility is equipped to support individuals with a history of trauma. Gaudenzia Inc provides specialized programs for adults and young adults, with distinct options for male and female patients. Prioritizing high-quality, personalized recovery plans, this institution is committed to guiding individuals through addiction challenges toward sustained sobriety.
In York, PA, Gaudenzia Inc is a leading provider of services for individuals struggling with substance use disorders, specifically for adult men. This establishment provides extended residential stays and transitional living options within a supportive atmosphere tailored for male residents. Gaudenzia Inc utilizes approaches such as 12-step facilitation, anger management, and brief interventions, serving adults, older adults, and younger adults in need of complete recovery support. The facility's dedication to high-quality treatment and customized plans establishes it as a reliable option for those desiring a structured, gender-focused path to recovery.
Gaudenzia Inc, situated in Berwick, PA, provides comprehensive substance use disorder services, encompassing intensive outpatient, outpatient, and medication-assisted treatment options like methadone, buprenorphine, and naltrexone. The center employs evidence-based therapeutic modalities such as cognitive behavioral therapy, the Matrix Model, and motivational interviewing. Gaudenzia Inc is dedicated to serving a broad spectrum of individuals, with specialized programs designed for adolescents, adult men, and adult women. Their commitment to delivering high-quality care extends to both adults and young individuals, distinguished by personalized recovery strategies and robust support systems.
Gaudenzia Inc, situated in Philadelphia, PA, is a prominent addiction treatment provider dedicated to assisting adults and young adults in their recovery from substance use disorders. They provide a range of services, including intensive outpatient care, standard outpatient programs, and medication-assisted treatment options such as methadone, buprenorphine, or naltrexone. Employing scientifically supported therapeutic strategies like 12-step facilitation, cognitive behavioral therapy, and contingency management, Gaudenzia Inc prioritizes a personalized approach to healing. The center welcomes both male and female individuals, ensuring that all clients receive thorough support designed for their unique circumstances. Gaudenzia Inc distinguishes itself through its unwavering dedication to superior treatment and bespoke recovery plans, establishing it as a premier destination for effective addiction recovery.
Gaudenzia Inc, located in Lancaster, PA, delivers extensive long-term and around-the-clock residential care for adults battling substance use disorders. The facility's robust program integrates techniques such as anger management, cognitive behavioral therapy, and motivational interviewing. Emphasizing the support of adult women, seniors, and young adults who have faced intimate partner violence, domestic abuse, or sexual assault, the center customizes its interventions to address individual challenges. Gaudenzia Inc in Lancaster is recognized for its empathetic approach and reliance on proven therapeutic strategies, positioning it as a premier option for individuals pursuing effective addiction recovery and assistance.
Gaudenzia Inc in Erie, PA provides exceptional services through various customized approaches. This location features extended residential care within a secure, nurturing atmosphere for adult women managing substance use disorders and co-occurring mental health issues. Emphasizing 12-step principles, cognitive-behavioral strategies, and concise interventions, Gaudenzia offers complete assistance to individuals with histories of trauma, such as domestic abuse and sexual assault. This facility serves adults, older adults, and younger adults, offering specific support to female patients. Gaudenzia Inc distinguishes itself through its dedication to comprehensive recovery and personalized treatment pathways.
Opioid Use Disorder (OUD): Key Facts
Classification
Opioid Use Disorder (OUD)
Prevalence
2.1 million adults with OUD in the US (SAMHSA)
Overdose deaths
80,000+ opioid overdose deaths/year in US (CDC)
Primary substances
Fentanyl, heroin, oxycodone, hydrocodone
Gold standard treatment
Medication-Assisted Treatment (MAT)
MAT effectiveness
Reduces overdose deaths by 50%+ (NIDA)
FDA-approved medications
Buprenorphine (Suboxone), Methadone, Naltrexone (Vivitrol)
Emergency reversal
Naloxone (Narcan)
Opioid Overdose Emergency: Know the Signs
An opioid overdose can kill within minutes. If you see these signs, act immediately:
Overdose warning signs
- Blue or purple lips and fingernails (cyanosis)
- Pinpoint (extremely small) pupils
- Slow, shallow, or stopped breathing
- Unresponsive to shouting or sternal rub
- Gurgling or choking sounds
- Limp body, pale or clammy skin
What to do
- Call 911 immediately — most states have Good Samaritan laws protecting callers
- Administer naloxone (Narcan) if available — nasal spray or injection
- Perform rescue breathing — one breath every 5 seconds
- Place in recovery position (on their side) to prevent choking
- Give a second dose of naloxone after 2-3 minutes if no response
- Stay until help arrives — naloxone wears off in 30-90 minutes
National Overdose Prevention Hotline: 911 | SAMHSA Helpline: 1-800-662-4357 (24/7, free, confidential)
What Is Opioid Use Disorder?
DSM-5 diagnostic criteria
Opioid Use Disorder (OUD) is a chronic, relapsing brain condition defined by the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). It is diagnosed when a person meets at least two of eleven criteria within a 12-month period, including: taking opioids in larger amounts or for longer than intended, persistent desire or unsuccessful efforts to cut down, spending excessive time obtaining or using opioids, cravings, failure to fulfill major obligations, continued use despite social or interpersonal problems, giving up important activities, use in physically hazardous situations, continued use despite physical or psychological problems, tolerance, and withdrawal.
Severity classification
OUD severity is classified based on the number of criteria met: mild (2-3 criteria), moderate (4-5 criteria), and severe (6 or more criteria). Severe OUD carries the highest risk of overdose death and typically requires the most intensive treatment, including medication-assisted treatment. Even mild OUD warrants professional intervention, as the disorder tends to progress without treatment.
Opioids vs. opiates
The term "opiates" refers specifically to natural compounds derived from the opium poppy (morphine, codeine). "Opioids" is the broader term that includes opiates plus semi-synthetic drugs (oxycodone, hydrocodone, heroin) and fully synthetic drugs (fentanyl, methadone, tramadol). All opioids bind to mu-opioid receptors in the brain, producing pain relief, euphoria, and respiratory depression — the mechanism that causes fatal overdoses.
The Opioid Epidemic: Fentanyl Crisis
Three waves of the opioid epidemic
The US opioid crisis has unfolded in three distinct waves. The first wave (1990s) was driven by aggressive marketing of prescription opioids — OxyContin, Vicodin, Percocet — leading doctors to overprescribe and millions of patients to develop dependence. The second wave (around 2010) saw a surge in heroin use as people with prescription opioid addiction shifted to cheaper, more accessible heroin. The third wave (2013-present) is defined by illicitly manufactured fentanyl and its analogs, which now account for the majority of opioid overdose deaths in the United States.
Why fentanyl changed everything
Fentanyl is a fully synthetic opioid that is 50-100 times more potent than morphine and approximately 50 times more potent than heroin. A lethal dose of fentanyl is just 2 milligrams — roughly the size of a few grains of salt. Because fentanyl is cheap to manufacture and extremely potent by weight, drug traffickers mix it into heroin, cocaine, methamphetamine, and counterfeit prescription pills. Many people who die from fentanyl overdoses did not know they were consuming it. Counterfeit pills made to look like oxycodone (M30), Xanax, or Adderall frequently contain lethal doses of fentanyl.
Current impact
According to the CDC, over 80,000 Americans die from opioid overdoses each year, with synthetic opioids (primarily illicit fentanyl) responsible for roughly 75% of those deaths. Opioid overdose is now the leading cause of accidental death for Americans under 50. The crisis affects every demographic, geographic region, and socioeconomic group in the country.
Opioid Withdrawal Timeline
Opioid withdrawal is intensely uncomfortable but rarely life-threatening on its own. The timeline varies depending on whether the person was using short-acting opioids (heroin, oxycodone, hydrocodone) or long-acting opioids (methadone, extended-release morphine).
Short-acting opioids (heroin, oxycodone)
- 6-12 hours: Onset of symptoms — anxiety, muscle aches, sweating, yawning, runny nose
- 24-48 hours: Escalation — insomnia, diarrhea, nausea, vomiting, abdominal cramps, dilated pupils
- 48-72 hours: Peak severity — intense cravings, body aches, goosebumps, rapid heartbeat
- 5-7 days: Acute symptoms begin to subside
- 1-2 weeks: Most physical symptoms resolve
Long-acting opioids (methadone, ER morphine)
- 24-48 hours: Delayed onset of symptoms
- 3-5 days: Symptoms escalate and peak
- 5-10 days: Peak and plateau of acute withdrawal
- 10-20 days: Gradual improvement of physical symptoms
- 2-3 weeks: Most acute symptoms resolve
Post-Acute Withdrawal Syndrome (PAWS)
After acute withdrawal resolves, many people experience Post-Acute Withdrawal Syndrome (PAWS) — a set of prolonged symptoms including anxiety, depression, insomnia, fatigue, difficulty concentrating, and mood swings that can persist for weeks to months. PAWS is the leading cause of relapse in the first year of recovery and is a key reason why ongoing treatment and support are essential after detox.
Why medical detox matters
While opioid withdrawal itself is rarely fatal, the extreme discomfort drives many people to relapse during detox — and relapse after a period of abstinence is when overdose risk is highest, because tolerance has decreased. Medically supervised detoxification uses medications like buprenorphine, clonidine, and comfort medications to manage symptoms safely, dramatically reducing relapse during the withdrawal period.
Medication-Assisted Treatment (MAT)
Medication-Assisted Treatment is the gold standard for opioid use disorder, combining FDA-approved medications with counseling and behavioral therapies. Research from NIDA shows MAT reduces opioid overdose deaths by more than 50%, decreases illicit opioid use, reduces criminal activity, improves social functioning, and increases treatment retention. Despite this evidence, fewer than 20% of people with OUD receive MAT — a treatment gap that costs tens of thousands of lives each year.
Buprenorphine (Suboxone)
Type: Partial opioid agonist
Buprenorphine activates opioid receptors just enough to prevent withdrawal and cravings without producing the intense euphoria of full agonists. It has a "ceiling effect," meaning higher doses do not increase effects — significantly reducing overdose risk. Suboxone combines buprenorphine with naloxone to deter misuse.
Setting: Can be prescribed by any licensed prescriber in office-based settings (OBOT), pharmacies, or telehealth.
Methadone
Type: Full opioid agonist
Methadone is a long-acting opioid that stabilizes brain chemistry, eliminates withdrawal symptoms, and blocks the euphoric effects of other opioids at proper doses. It has the longest track record of any MAT medication, with over 50 years of evidence supporting its effectiveness.
Setting: Must be dispensed daily at a certified Opioid Treatment Program (OTP/methadone clinic). Take-home doses earned over time with compliance.
Naltrexone (Vivitrol)
Type: Opioid antagonist (blocker)
Naltrexone completely blocks opioid receptors, preventing any opioid from producing effects. The extended-release injection (Vivitrol) is administered monthly and eliminates the need for daily medication adherence. Unlike buprenorphine and methadone, naltrexone has no abuse potential and is not a controlled substance.
Requirement: Patient must be fully detoxed (7-14 days opioid-free) before starting naltrexone to avoid precipitated withdrawal.
MAT medication comparison
The three FDA-approved MAT medications differ in mechanism, dispensing model, and patient fit. The table below summarizes the key distinctions:
| Medication | Type | DEA Schedule | Setting | Dispensing | Best for |
|---|---|---|---|---|---|
| Buprenorphine (Suboxone, Sublocade, Subutex, Zubsolv, Brixadi) | Partial agonist with ceiling effect | III | OBOT, telehealth, retail pharmacy | Take-home from day 1 (or monthly injection) | Most patients; rural areas; daily clinic not feasible |
| Methadone | Full mu-opioid agonist | II | OTP only (42 CFR Part 8) | Daily at clinic → take-home after 90 days | Severe OUD; prior buprenorphine failure; long-standing dependence |
| Naltrexone (Vivitrol) | Opioid antagonist (blocker) | Not controlled | Any prescriber; injection at clinic | Monthly IM injection (380 mg) | Highly motivated; post-detox (7-14 days opioid-free); no abuse potential desired |
All three are effective; the best choice is the one the patient will actually take consistently. Adherence, not pharmacology, is the dominant predictor of outcomes. Buprenorphine and methadone are first-line for active opioid use; naltrexone requires complete detox before initiation.
Types of Opioid Treatment Programs
OTP / Methadone Clinics
Opioid Treatment Programs are federally certified clinics that dispense methadone and provide comprehensive services including counseling, drug testing, and case management. Patients visit daily initially, earning take-home privileges over time.
OBOT (Office-Based Treatment)
Office-Based Opioid Treatment allows any licensed prescriber to treat OUD with buprenorphine in a standard medical office or via telehealth. This model dramatically increases access, especially in rural areas with no OTPs. Patients fill prescriptions at regular pharmacies.
Residential (inpatient) programs provide 24/7 structured care for 30-90 days. Best for severe OUD, polysubstance use, co-occurring mental health disorders, or patients who need separation from their environment. Most residential programs offer MAT as part of treatment.
IOP programs provide 9-20 hours of structured treatment per week while allowing patients to live at home. Combines group therapy, individual counseling, and MAT. Effective for moderate OUD or as a step-down from residential treatment.
Standard outpatient involves 1-2 sessions per week — typically individual therapy and/or group sessions combined with MAT. Suitable for mild to moderate OUD or as a long-term maintenance level of care after completing more intensive treatment.
Medical detox provides 3-7 days of supervised withdrawal management using medications to ease symptoms. Detox alone is not treatment — it must be followed by ongoing MAT and/or behavioral therapy. Detox without continued care has very high relapse rates.
Naloxone: The Overdose Reversal Medication
What naloxone does
Naloxone (brand name Narcan) is an opioid antagonist that rapidly reverses opioid overdose by displacing opioids from receptors in the brain. It restores normal breathing within 2-5 minutes in most cases. Naloxone has no effect on people who do not have opioids in their system and has virtually no abuse potential. Since 2023, Narcan nasal spray is available over the counter at pharmacies nationwide without a prescription.
How to use naloxone nasal spray
Using Narcan nasal spray requires no medical training:
- Peel back the package and remove the device
- Tilt the person's head back and insert the nozzle into one nostril
- Press the plunger firmly to deliver the full dose
- If no response in 2-3 minutes, administer a second dose in the other nostril
- Continue rescue breathing and call 911 — naloxone wears off in 30-90 minutes, and the person may stop breathing again
Where to get naloxone for free
Many harm reduction organizations, health departments, and community pharmacies distribute naloxone for free or at low cost. SAMHSA's Opioid Overdose Prevention Toolkit and state naloxone access programs provide resources. Most states have standing orders allowing pharmacists to dispense naloxone without an individual prescription. If you or someone you know uses opioids, carrying naloxone can save a life.
Frequently Asked Questions About Opioid Treatment
What is medication-assisted treatment (MAT) for opioid addiction?
Medication-Assisted Treatment (MAT) combines FDA-approved medications — methadone, buprenorphine (Suboxone), or naltrexone (Vivitrol) — with counseling and behavioral therapies. These medications reduce cravings, prevent withdrawal symptoms, and normalize brain chemistry, allowing people to focus on recovery. MAT is the most effective treatment for opioid use disorder: it reduces overdose deaths by more than 50%, decreases illicit drug use, and improves treatment retention rates (NIDA).
How long does opioid withdrawal last?
The withdrawal timeline depends on the opioid used. Short-acting opioids like heroin and oxycodone cause symptoms within 6-12 hours that peak at 48-72 hours and subside over 5-7 days. Long-acting opioids like methadone produce delayed symptoms starting at 24-48 hours, peaking at 3-5 days, and lasting up to 2-3 weeks. Post-acute withdrawal symptoms (PAWS) — including anxiety, insomnia, and mood instability — may persist for weeks to months after acute withdrawal resolves.
Is buprenorphine (Suboxone) just replacing one addiction with another?
No — this is one of the most harmful misconceptions in addiction medicine. Buprenorphine is a partial opioid agonist prescribed at stable, controlled doses as part of comprehensive treatment. It does not produce euphoria when taken as directed, eliminates cravings, prevents withdrawal, and allows people to function normally — work, care for families, and rebuild their lives. Taking buprenorphine for OUD is no different than taking insulin for diabetes: it is evidence-based medication for a chronic medical condition.
What should I look for in an opioid treatment center?
Look for centers offering MAT options (buprenorphine, methadone, and/or naltrexone), accreditation from CARF or The Joint Commission, licensed medical staff experienced in addiction medicine, comprehensive assessment with individualized treatment plans, evidence-based therapies (CBT, contingency management), family support services, and strong aftercare planning. Verify they accept your insurance and offer the appropriate level of care for your situation.
Can I work while in opioid treatment?
Yes, especially with outpatient MAT programs. Outpatient treatment — including OBOT (office-based buprenorphine) and standard outpatient counseling — allows you to maintain work, family, and social responsibilities while receiving care. Intensive Outpatient Programs (IOP) typically meet 9-20 hours per week and can often be scheduled around work. Many employers are required to support recovery under the ADA and FMLA. Residential treatment requires time away but provides the most intensive support for severe cases.
What is fentanyl and why is it so dangerous?
Fentanyl is a fully synthetic opioid that is 50-100 times more potent than morphine. A lethal dose is just 2 milligrams. It is increasingly found in the illicit drug supply, mixed into heroin, cocaine, methamphetamine, and counterfeit prescription pills — often without the user's knowledge. Fentanyl is now responsible for roughly 75% of all opioid overdose deaths in the United States. Treatment for fentanyl addiction typically requires MAT (often at higher buprenorphine or methadone doses), naloxone training, and comprehensive behavioral support.
How long does MAT treatment last?
There is no fixed duration for MAT — treatment length should be individualized. Research consistently shows that longer treatment produces better outcomes. The American Society of Addiction Medicine (ASAM) recommends a minimum of one year of MAT, and many addiction specialists recommend indefinite maintenance for people with severe OUD, as the risk of fatal overdose is highest in the period after discontinuing MAT. The decision to taper off medication should be made collaboratively with a treatment provider when the patient is stable, has strong support systems, and is not facing major life stressors.
Is fentanyl in the drug supply near me?
Almost certainly yes. Fentanyl has been detected in the illicit drug supply in all 50 states. It is routinely found in heroin, counterfeit prescription pills (especially fake oxycodone M30s, Xanax, and Adderall), cocaine, and methamphetamine. DEA lab testing shows that 7 out of 10 counterfeit pills seized contain a potentially lethal dose of fentanyl. Fentanyl test strips — which can detect fentanyl before use — are available for free from many harm reduction organizations, health departments, and community pharmacies. The safest assumption is that any illicit substance may contain fentanyl.
Medical Review and Sources
Trusted Resources
Substance Abuse and Mental Health Services Administration
Federal agency providing information, resources, and treatment locator for substance abuse and mental health.
Helpline: 1-800-662-4357
National Institute on Drug Abuse
NIH institute advancing science on drug use and addiction causes, consequences, and treatment.
National Institute on Alcohol Abuse and Alcoholism
NIH institute supporting research on alcohol's impact on health and providing treatment resources.
Ready To Start Opioid Treatment?
Opioid addiction is a medical condition — not a moral failure. Medication-assisted treatment saves lives. Speak with a specialist who can help you find the right MAT program, detox center, or residential facility — 100% free and confidential, available 24/7.
Browse opioid addiction programs in states with the most treatment options.
Related conditions, treatment approaches, and levels of care.